Oncology News

In the latest installment of Residency to Retirement, experts outlined five success factors that physicians should consider incorporating into their permanent life insurance policy.

Among women eligible for Denmark’s national breast cancer screening program, those who had an intellectual disability were less likely to undergo recommended screening, according to findings published in JAMA Network Open.

Among patients with breast cancer in China, those who underwent adjuvant endocrine therapy had more prevalent and more severe menopausal symptoms, according to data published in Menopause.

In this episode, host Shikha Jain, MD, speaks with Michael Roizen, MD, author and chief wellness officer at the Cleveland Clinic, about developing tools that can help lead to a longer life, public health messaging in media and more.

Nathalie D. Mckenzie, MD, is a gynecologic oncologist and program director of the gynecologic oncology fellowship at AdventHealth Cancer Institute who has spent her career serving patients in countries with limited access to cancer therapies.

This year, researchers found that of patients with high-risk, early-stage ovarian cancer, 72% had one or more symptoms and 28% were asymptomatic.

In this edition, NCI director announces breast cancer diagnosis, neoadjuvant chemotherapy regimen in pancreatic cancer, gender harassment is in oncology and more.

Recent data suggest that the use of blood thinners may be unnecessary in women with a history of recurrent pregnancy loss and inherited thrombophilia, according to researchers.

Long travel times to facilities offering mammography substantially limited accessibility to breast cancer screening, particularly for women living in rural areas, according to data published in the Journal of the National Cancer Institute.

In this edition, cancer and COVID-19 increase risk for thromboembolism, glofitamab shows curative potential in lymphoma, efgartigimod improves platelet counts, and more.